
Brenda Libby Coleman
Examiner (ID: 16325, Phone: (571)272-0665 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 2611, 1624, 1611 |
| Total Applications | 3154 |
| Issued Applications | 1970 |
| Pending Applications | 485 |
| Abandoned Applications | 741 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7433052
[patent_doc_number] => 20040209870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds'
[patent_app_type] => new
[patent_app_number] => 10/761070
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47650
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10761070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/761070 | Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds | Jan 19, 2004 | Abandoned |
Array
(
[id] => 345245
[patent_doc_number] => 07498433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-03
[patent_title] => 'Process and intermediates for the preparation of olanzapine'
[patent_app_type] => utility
[patent_app_number] => 10/541604
[patent_app_country] => US
[patent_app_date] => 2004-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4775
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/498/07498433.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541604
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541604 | Process and intermediates for the preparation of olanzapine | Jan 15, 2004 | Issued |
Array
(
[id] => 620255
[patent_doc_number] => 07141672
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-28
[patent_title] => 'Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia'
[patent_app_type] => utility
[patent_app_number] => 10/753792
[patent_app_country] => US
[patent_app_date] => 2004-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8357
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/141/07141672.pdf
[firstpage_image] =>[orig_patent_app_number] => 10753792
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/753792 | Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia | Jan 7, 2004 | Issued |
Array
(
[id] => 7432741
[patent_doc_number] => 20040209846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Heterocyclic analgesic compounds and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/754101
[patent_app_country] => US
[patent_app_date] => 2004-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 59519
[patent_no_of_claims] => 204
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10754101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/754101 | Heterocyclic analgesic compounds and methods of use thereof | Jan 6, 2004 | Issued |
Array
(
[id] => 7276302
[patent_doc_number] => 20040235753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Oxytocin agonists'
[patent_app_type] => new
[patent_app_number] => 10/482102
[patent_app_country] => US
[patent_app_date] => 2003-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14446
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235753.pdf
[firstpage_image] =>[orig_patent_app_number] => 10482102
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/482102 | Oxytocin agonists | Dec 23, 2003 | Abandoned |
Array
(
[id] => 7466440
[patent_doc_number] => 20040198721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Novel crystal forms, methods for their preparation and method for preparation of olanzapine'
[patent_app_type] => new
[patent_app_number] => 10/746698
[patent_app_country] => US
[patent_app_date] => 2003-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5399
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198721.pdf
[firstpage_image] =>[orig_patent_app_number] => 10746698
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/746698 | Crystal forms, methods for their preparation and method for preparation of olanzapine | Dec 23, 2003 | Issued |
Array
(
[id] => 7325331
[patent_doc_number] => 20040138199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Benzoxazines and derivatives thereof as therapeutic agents'
[patent_app_type] => new
[patent_app_number] => 10/743852
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20794
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138199.pdf
[firstpage_image] =>[orig_patent_app_number] => 10743852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/743852 | Benzoxazines and derivatives thereof as therapeutic agents | Dec 21, 2003 | Abandoned |
Array
(
[id] => 6997408
[patent_doc_number] => 20050137186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Tetrahydrobenzazepines and their use'
[patent_app_type] => utility
[patent_app_number] => 10/740092
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18463
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137186.pdf
[firstpage_image] =>[orig_patent_app_number] => 10740092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/740092 | Tetrahydrobenzazepines and their use | Dec 17, 2003 | Abandoned |
Array
(
[id] => 5591466
[patent_doc_number] => 20060040918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Benzo d!azepine derivatives for the treatment of neurological disorders'
[patent_app_type] => utility
[patent_app_number] => 10/539385
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36928
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10539385
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/539385 | Benzazepine derivatives for the treatment of neurological disorders | Dec 17, 2003 | Issued |
Array
(
[id] => 326653
[patent_doc_number] => 07514424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-07
[patent_title] => 'Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/540456
[patent_app_country] => US
[patent_app_date] => 2003-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12227
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/514/07514424.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540456
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540456 | Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists | Dec 16, 2003 | Issued |
Array
(
[id] => 837138
[patent_doc_number] => 07393954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-01
[patent_title] => 'Process for the production of pentostatin aglycone and pentostatin'
[patent_app_type] => utility
[patent_app_number] => 10/734545
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7206
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/393/07393954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10734545
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/734545 | Process for the production of pentostatin aglycone and pentostatin | Dec 11, 2003 | Issued |
Array
(
[id] => 7238835
[patent_doc_number] => 20040157826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Novel heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/727911
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47881
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727911
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727911 | Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors | Dec 3, 2003 | Issued |
Array
(
[id] => 7216377
[patent_doc_number] => 20050054634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Azepinoindole derivatives as pharmaceutical agents'
[patent_app_type] => utility
[patent_app_number] => 10/895431
[patent_app_country] => US
[patent_app_date] => 2003-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 74175
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054634.pdf
[firstpage_image] =>[orig_patent_app_number] => 10895431
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/895431 | Azepinoindole derivatives as pharmaceutical agents | Dec 1, 2003 | Issued |
Array
(
[id] => 7291018
[patent_doc_number] => 20040110742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Dihydrodiaryloxazepine derivative and pharmaceutical composition containing the same'
[patent_app_type] => new
[patent_app_number] => 10/724179
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27901
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110742.pdf
[firstpage_image] =>[orig_patent_app_number] => 10724179
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/724179 | Dihydrodiaryloxazepine derivative and pharmaceutical composition containing the same | Nov 30, 2003 | Issued |
Array
(
[id] => 5023515
[patent_doc_number] => 20070149481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'N,n-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/532263
[patent_app_country] => US
[patent_app_date] => 2003-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 28237
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149481.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532263
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532263 | N,n-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors | Nov 25, 2003 | Abandoned |
Array
(
[id] => 7338221
[patent_doc_number] => 20040132993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Antiviral and antimicrobial guanidine or biguanidine derivatives'
[patent_app_type] => new
[patent_app_number] => 10/720441
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13589
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10720441
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/720441 | Antiviral and antimicrobial guanidine or biguanidine derivatives | Nov 24, 2003 | Abandoned |
Array
(
[id] => 658937
[patent_doc_number] => 07105679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-12
[patent_title] => 'Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 10/719875
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71481
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/105/07105679.pdf
[firstpage_image] =>[orig_patent_app_number] => 10719875
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/719875 | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators | Nov 20, 2003 | Issued |
Array
(
[id] => 7453432
[patent_doc_number] => 20040067936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine'
[patent_app_type] => new
[patent_app_number] => 10/363436
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 2956
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067936.pdf
[firstpage_image] =>[orig_patent_app_number] => 10363436
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/363436 | Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine | Nov 19, 2003 | Abandoned |
Array
(
[id] => 7310535
[patent_doc_number] => 20040142921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity'
[patent_app_type] => new
[patent_app_number] => 10/715622
[patent_app_country] => US
[patent_app_date] => 2003-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10393
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142921.pdf
[firstpage_image] =>[orig_patent_app_number] => 10715622
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/715622 | Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity | Nov 17, 2003 | Issued |
Array
(
[id] => 7238859
[patent_doc_number] => 20040157828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/478619
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9502
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157828.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478619 | Protease inhibitors | Nov 16, 2003 | Abandoned |